Effects of a long‐acting GLP‐1 mimetic (PF‐04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
PF‐04603629, an exendin‐transferrin fusion protein, is a long‐acting glucagon‐like peptide‐1 (GLP‐1) mimetic. This randomized, double‐blind study characterized the safety and pharmacodynamics of a single dose of PF‐04603629 (n = 57; 1–70 mg) or placebo (n = 14) in subjects with type 2 diabetes mellitus (T2DM). There were dose‐dependent decreases from baseline in day 6 glucose area under the curve following a mixed meal test (−27 ± 12% with 70 mg). Most treatment‐related adverse events were gastrointestinal, with nausea and vomiting most frequent at 70 mg. Pulse rate (PR) and diastolic blood pressure (DBP) increased dose dependently within the normal range. At 24 h postdose mean PR increased 23 ± 9 bpm and mean DBP increased 10 ± 5 mmHg with 70 mg. In conclusion, PF‐04603629 exhibited efficacy and tolerability consistent with its mechanism of action; however, PR and DBP increased. Similar effects have been reported occasionally with other GLP‐1 mimetics. These data underscore the importance of careful assessments of haemodynamic effects in GLP‐1 analogues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials
Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000094221.86888.ae · Cited by 1,391
Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P. A., Rodriguez-Pattzi, H., Olvera-Alvarez, I., Hale, P. M., Zdravkovic, M., & Bode, B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61246-5 · Cited by 1,057 · cited 1×
“6 mmHg) and no significant effect on DBP despite a 4 kg weight loss [6].”
BackgroundYamamoto, H., Kishi, T., Lee, C. E., Choi, B. J., Fang, H., Hollenberg, A. N., Drucker, D. J., & Elmquist, J. K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02939.2003 · Cited by 294
Takara, A., Ogawa, H., Endoh, Y., Mori, F., Yamaguchi, J.-I., Takagi, A., Koyanagi, R., Shiga, T., Kasanuki, H., & Hagiwara, N. (2010) · Cardiovascular Diabetology · doi:10.1186/1475-2840-9-1 · Cited by 61
Cited by
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial.
Rodbard, H. W., Lingvay, I., Reed, J., de la Rosa, R., Rose, L., Sugimoto, D., Araki, E., Chu, P.-L., Wijayasinghe, N., & Norwood, P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00070 · Cited by 412
“0 mg compared with placebo has been previously reported in patients treated with GLP-1RAs (31, 32); however, the reasons for this hemodynamic effect are unclear (33).”
BackgroundRobinson, L. E., Holt, T. A., Rees, K., Randeva, H. S., & O'Hare, J. P. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-001986 · Cited by 296
“rise in the heart rate (a mean increase of 23 bpm at 24 h after injection of the higher dose studied), together with a rise in the diastolic blood pressure.(21) While there is no evidence to date that these agents (short-acting or long-acting) increase cardiovascular”
BackgroundMonami, M., Ahrén, B., Dicembrini, I., & Mannucci, E. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12000 · Cited by 259
Seino, Y., Terauchi, Y., Osonoi, T., Yabe, D., Abe, N., Nishida, T., Zacho, J., & Kaneko, S. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13082 · Cited by 127
Metadata
- Authors
- Gustavson, S. M., Chen, D., Somayaji, V., Hudson, K., Baltrukonis, D. J., Singh, J., Boyden, T. L., & Calle, R. A.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2011-09-28
- Volume
- 13
- Issue
- 11
- Pages
- 1056-1058
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2100089259
- Cited by
- 21
- References
- 4
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of a long‐acting GLP‐1 mimetic (PF‐04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus. https://app.cochat.ai/papers/10.1111/j.1463-1326.2011.01479.x
- The paper
- Gustavson, S. M., Chen, D., Somayaji, V., Hudson, K., Baltrukonis, D. J., Singh, J., Boyden, T. L., & Calle, R. A. (2011). Effects of a long‐acting GLP‐1 mimetic (PF‐04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/j.1463-1326.2011.01479.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.